ArticlePLOS global public health2025
City-wide built environment SARS-CoV-2 detection for COVID-19 surveillance.
Article in PLOS global public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Built environment surveillance has shown promise for monitoring COVID-19 burden at granular geographic scales, but its utility for surveillance across larger areas and populations is unknown. Our study aims to evaluate the role of built environment detection of SARS-CoV-2 for the surveillance of COVID-19 across broad geographies and populations. We conducted a prospective city-wide sampling study to examine the relationship between SARS-CoV-2 on floors and COVID-19 burden. We used non-parametric correlation analyses and linear models to evaluate associations between SARS-CoV-2 signals and COVID-19 outcomes, across multiple locations/populations over time. Sampling sites included schools, libraries, and emergency departments in the capital city of Ottawa, Canada, from October 2022 to March 2023. Floor sampling was performed across spaces, and outcomes were evaluated at aggregate levels. Detection (presence/absence) and quantification (viral load) of SARS-CoV-2 was determined by reverse-transcriptase polymerase chain reaction conducted on floor swabs collected weekly at study locations. The main outcomes, and measures of COVID-19 burden, were (1) weekly regional wastewater signal and (2) weekly admitted COVID-19 patient census from hospitals. We collected 1,863 built environment floor samples over the 6-month study period, with an overall swab positivity for SARS-CoV-2 of 45% (95%CI 43%-48%). We found a strong correlation between overall built environmental swab viral load and hospital COVID-19 census (Spearman's r = 0.64, p = 0.0017), but no correlation between regional wastewater and hospital COVID-19 census (Spearman's r = -0.15, p = 0.5). We found a strong correlation (Spearman's r = 0.76, p = 9x10-5) between hospital-specific swab viral copy number and hospital-specific COVID-19 census, which is a likely driver of the overall association between swab load and census. Built environment surveillance of SARS-CoV-2 from hospitals was strongly correlated with hospital burden with improved delineation of hospital COVID-19 cases compared to regional wastewater. These findings support the use of built environment surveillance for quantification of infectious burden amongst institutionalized groups.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.